Novartis AG

Type: Company
Name: Novartis AG
Nationality: Switzerland
Web Address: http://www.novartis.com
Fact Sheet: Fact Sheet for Novartis India Ltd
First reported 23 hours ago - Updated 16 hours ago - 3 reports

All life-saving drugs may come under price cap

NPPA suggests expanding the list of essential medicines whose prices are controlledA Present capThe prices of the 348 formulations in the NLEM list are controlledSuggestionNPPA’s note has recommended revising the NLEM list to include therapeutic areas ... [Published rediff.com - 16 hours ago]
First reported 20 hours ago - Updated 20 hours ago - 1 reports

Innovative treatments for diseases that commonly affect older people

The world’s population is aging. The United Nations Population Fund (UNFPA) attributes this “demographic revolution affecting the entire world” to lower fertility, increased child survival and better health.In the Philippines, the latest Census of Population ... [Published Philippine Daily Inquirer - 20 hours ago]
First reported Oct 24 2014 - Updated Oct 24 2014 - 1 reports

Novartis’ clinical data shows promise for ankylosing spondylitis

New data for a drug to treat the condition; ankylosing spondylitis has been developed by pharma company, Novartis Pharmaceuticals it has been announced.The data has shown positive results for secukinumab and has demonstrated the benefits it can offer ... [Published Pharma Field - Oct 24 2014]
First reported Oct 23 2014 - Updated Oct 24 2014 - 2 reports

Novartis reports positive results from two Phase III trials of secukinumab in ankylosing spondylitis

Novartis has reported positive results from its Phase III trials MEASURE 1 and MEASURE 2 of its investigational medicine AIN457 (secukinumab) in patients with ankylosing spondylitis (AS). ... [Published PBR - News - Oct 24 2014]
First reported Oct 24 2014 - Updated Oct 24 2014 - 1 reports

VIDEO: 2014 Top Company for Diversity Management Progress: Novartis Pharmaceuticals Corporation

Top Company for Diversity Management Progress: Novartis Pharmaceuticals CorporationAccepting Award: Christi Shaw, PresidentReasons for Honor:How does a company go from being No. 21 on the DiversityInc Top 50 to No. 13 the next year to No. 6 and then to ... [Published Diversity Inc - Oct 24 2014]
First reported Oct 23 2014 - Updated Oct 23 2014 - 7 reports

Novartis' Secukinumab Receives Favorable FDA Panel Vote

Updates on the regulatory front are eagerly awaited by investors in the pharma/biotech sector as they impact the share price of the concerned company. Regulatory updates include events like filing of marketing applications, acceptance of these applications ... [Published Yahoo! Finance - Oct 23 2014]
First reported Oct 23 2014 - Updated Oct 23 2014 - 2 reports

Quartet Medicine scores $17 mln Series A

Quartet Medicine has closed $17 million in Series A financing. Atlas Venture led the round with participation from Novartis Venture Funds, Pfizer Venture Investment and Partners Innovation Fund . In conjunction with the funding, Henry Skinner ... [Published PE Hub Blog - Oct 23 2014]
First reported Oct 23 2014 - Updated Oct 23 2014 - 1 reports

Novartis AG (NVS) Showing Support Near $87.60

The patented option-trade picking algorithms that power MarketIntelligenceCenter.com's Artificial Intelligence Center have selected a covered-call trade on Novartis AG (NVS) that includes 3.12% downside protection. Sell one contract of the Dec. '14 $87.50 ... [Published MarketIntelligenceCenter.com - Oct 23 2014]
First reported Oct 23 2014 - Updated Oct 23 2014 - 1 reports

Novartis 3Q 2014 -- Forecast

FRANKFURT--The following is a summary of analysts' forecasts for Novartis AG (NVS) third-quarter results, based on a poll of nine analysts conducted by Dow Jones Newswires (figures in million dollars, EPS in dollar, target price in francs, according to ... [Published Capital.gr - Oct 23 2014]
First reported Oct 23 2014 - Updated Oct 23 2014 - 1 reports

Novartis Reaffirms Commitment to Vietnam Community Healthcare

Novartis reaffirmed its commitment to enhancing community healthcare in Vietnam as the research-based Swiss healthcare company celebrated the 2nd anniversary of its social venture program in the country, CùngSốngKhỏe.Launched in 2012, CùngSốngKhỏe ... [Published Vietnam Business Forum - Oct 23 2014]
First reported Oct 23 2014 - Updated Oct 23 2014 - 1 reports

Novartis drafts TV celeb Nick Cannon to talk up importance of flu vaccines

Nick CannonNovartis ( $NVS ) may be selling off most of its vaccines business to GlaxoSmithKline ( $GSK ), but for now, it's hanging onto its flu vaccines. And to help show Americans just how important those flu vaccines are, it's teamed up with entertainer ... [Published FierceVaccines - Oct 23 2014]
First reported Oct 23 2014 - Updated Oct 23 2014 - 1 reports

An Application for the Trademark "NODOZ ALERTNESS AID" Has Been Filed by Novartis

By a News Reporter-Staff News Editor at Pharma Business Week -- According to news reporting originating from Washington, D.C. , by NewsRx journalists, a trademark application has been made for "NODOZ ALERTNESS AID" by Mary F. Leheny , representing Novartis ... [Published 4 Traders - Oct 23 2014]

Quotes

...“The method is not very good for gene discovery, but for candidate screening it is perfect,” said Couthouis. "You just have to sequence what you need.”"
...the U S is the shining star in the global growth constellation so that will be an important number from a psychological standpoint," McCarthy said. "I think it should be pretty good at 3.2 percent. The first estimate is always a bit of a wild card."
"There are groups today that spend millions of dollars perfecting that comfort," Gandhi says. "We believe that we can get to that level, but it's all about how we integrate our micro-machine into the contact lens."
..."We want to target those segments where volumes are high because consumption is high," stated an NPPA official, adding "however, there is a huge price parity. The expansion of NLEM will try to address this loophole." Specifically, the changes proposed by the NPPA target drugs in the anti-infective, cardiac, gastro-intestinal, respiratory, anti-diabetic, analgesic...

More Content

All (2878) | News (2202) | Reports (0) | Blogs (604) | Audio/Video (2) | Fact Sheets (32) | Press Releases (28)
sort by: Date | Relevance
Novel Exome Screen Points to Tubulin as ALS Gene [Published Alzheimer Research Forum - 2 hours ago]
Atlas leads $17mm Series A financing for Quarte... [Published BioPortfolio - 12 hours ago]
All life-saving drugs may come under price cap [Published rediff.com - 16 hours ago]
Bench thinks pink [Published Philippine Star - 18 hours ago]
Trading could get scary next week as Fed day looms [Published Yahoo! Malaysia - 18 hours ago]
Trading could get scary next week as Fed day looms [Published CNBC - 20 hours ago]
Innovative treatments for diseases that commonl... [Published Philippine Daily Inquirer - 20 hours ago]
Replacing Glucose Tests With An Always-On Senso... [Published Fast Company - 22 hours ago]
All life-saving drugs may come under price cap [Published FirstWord Pharma - 22 hours ago]
Calendar: What investors need to know for the w... [Published Globe and Mail - 22 hours ago]
Centre sets up think tank for national IPR policy [Published Times of India - 22 hours ago]
Pvt sector deserts war on TB, funding down 33% ... [Published Times of India - 23 hours ago]
All life-saving drugs may come under price cap [Published Business Standard India - 23 hours ago]
Govt sets up 6-member IPR think tank [Published Times of India - 23 hours ago]
Bristol-Myers Squibb's (BMY) CEO Lamberto Andre... [Published Seeking Alpha - Oct 24 2014]
FDA Advisory Committee Recommends Approval of A... [Published MedEsthetics Magazine - Oct 24 2014]
Examination of Myriad-Mayo Guidance Comments --... [Published JD Supra - Oct 24 2014]
Novel oral anticoagulants vs. warfarin: The deb... [Published Orthopedics Today - Oct 24 2014]
Exploration of devices to treat resistant hyper... [Published Orthopedics Today - Oct 24 2014]
Bristol-Myers Tops Estimates as Sales From Key ... [Published Washington Post - Oct 24 2014]
Pasireotide for Acromegaly Study Now Published [Published Diabetes Care - Oct 24 2014]
Novartis AG (NVS) Showing Bearish Technicals Wi... [Published Individual.com - Oct 24 2014]
ALS-008176 shows promise in healthy adults with... [Published Orthopedics Today - Oct 24 2014]
ImmunoGen's (IMGN) CEO Daniel Junius on Q1 2015... [Published Seeking Alpha - Oct 24 2014]
Novartis’ clinical data shows promise for ankyl... [Published Pharma Field - Oct 24 2014]
Quartet Medicine secures $17 million in Series ... [Published Individual.com - Oct 24 2014]
New Implantable Eye Devices Could Replace Readi... [Published Medical Design Online - Oct 24 2014]
The Daily Startup: Airbnb Could Soon Be Worth $... [Published WSJ.com: Venture Capital Dispatch - Oct 24 2014]
VIDEO: 2014 DiversityInc Special Awards [Published Diversity Inc - Oct 24 2014]
East Coast Biotech Roundup: PureTech, Celgene, ... [Published Xconomy - Oct 24 2014]
1 2 3 4 5 6 7 8 9 10 ...
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
The Daily Startup: Airbnb Could Soon Be Worth $... [Published WSJ.com: Venture Capital Dispatch - Oct 24 2014]
Brian Chesky, co-founder and chief executive officer of Airbnb Inc.Bloomberg News Airbnb Inc. has met with investors about an employee stock sale, Douglas MacMillan, Mike Spector and Evelyn M. Rusli reported for The Wall Street Journal . The company ...
Novartis AG (NVS) Showing Bearish Technicals Wi... [Published MarketIntelligenceCenter.com - Oct 24 2014]
Option-trade picking algorithms patented by MarketIntelligenceCenter.com found a trading opportunity with Novartis AG (NVS) that should provide a 2.05% return in just 85 days. Sell one Jan. '15 call at the $87.50 level for each 100 shares of Novartis ...
Novartis reports positive results from two Phas... [Published PBR - News - Oct 24 2014]
Novartis has reported positive results from its Phase III trials MEASURE 1 and MEASURE 2 of its investigational medicine AIN457 (secukinumab) in patients with ankylosing spondylitis (AS). ...
BioNews [10.23.14] [Published eClinical Trends - Oct 23 2014]
Top News HeadlineCompanyType Novartis racks up a new slate of promising PhIII data for secukinumab NovartisPositive Results Johnson & Johnson To Launch J-Labs Incubator At Houston’s TMC To Boost Biotechs Johnson & JohnsonIncubators in ...
List of banks that will support Apple Pay in co... [Published 9 to 5 Mac - Oct 23 2014]
Visa has published a list of banks and financial institutions that will support Apple Pay in the United States ‘in the coming weeks’, while Mastercard has it’s own list of supported banks arriving in the coming months. The mobile payments service ...
1 2 3 4 5 6 7 8 9 10 ...

Audio/Video

sort by: Date | Relevance
Lackluster Day On Wall Street Equals A Mixed Close [Published Wall Street Journal What's News - Jul 15 2014]
TECH PM -- Google and Novartis Team Up [Published Wall Street Journal Tech News Briefing - Jul 15 2014]
1

Press Releases

sort by: Date | Relevance
MorphoSys Announces Clinical Milestone in Ophth... [Published GlobeNewswire: Acquisitions News - Oct 20 2014]
Marketing Application Update, Acquisitions, Col... [Published Financial Services - Oct 10 2014]
Technical Updates on Health Care Sector Stocks ... [Published Financial Services - Oct 06 2014]
Upcoming Presentations, Technical Update, Study... [Published Financial Services - Sep 05 2014]
Pharma Equities Technical Analysis -- Sanofi, A... [Published Financial Services - Aug 26 2014]
1 2 3 4 5 6
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.